Molecular-diagnostics company Molbio Diagnostics has opened its IPO today with a price band of Rs. 768–807 per share. The offering is worth approximately Rs. 939.70 cr. and will remain open until August 12. The issue comprises a fresh issue of Rs. 200 cr. and an offer for sale of about Rs. 739.70 cr.
Molbio is known for its point-of-care diagnostic technology and is seeking to strengthen manufacturing and research capabilities. The IPO has generated investor interest, with unofficial grey-market indicators pointing towards a premium, although such indications are not guaranteed listing returns.
